Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from LLY

Dow Jones Futures Fall Amid Jobs Report As Fed Doubts Grow; Spot Bitcoin ETFs Loom

The major indexes held up Thursday with bullish action from many leading stocks. The December jobs report and spot Bitcoin ETF approvals loom.

Investors Business Daily

Dow Jones Futures Fall After Techs Skid To Start 2024; Celsius, Eli Lilly Flash Buy Signals

Big tech winners led Tuesday's skid. Weight loss plays Celsius and Eli Lilly flashed buy signals. Tesla and Microsoft held up.

Investors Business Daily

Dow Jones Futures Fall To Start 2024; Tesla Deliveries Due As Rival Races Ahead

After a big 2023, the market rally looks strong heading into 2024. Tesla deliveries are due after key rivals reported.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyzing 3 Pharma Stocks for Year-End Gains?

The pharma industry is well-positioned for expansion owing to growing healthcare spending and the adoption of cutting-edge technologies to develop new drugs. Amid this backdrop, let’s analyze the investment prospects of fundamentally strong pharma stocks Eli Lilly (LLY), Teva Pharmaceutical (TEVA), and Johnson & Johnson (JNJ) for year-end gains. Read…

StockNews.com

3 Solid Pharma Stocks for a Healthy Year-End Portfolio

The pharma industry is transforming due to the rapid adoption of AI and global healthcare spending, fostering innovation and patient care advancements. Therefore, fundamentally sound pharma stocks Eli Lilly (LLY), Wave Life Sciences (WVE) and Johnson & Johnson (JNJ) might be worth adding to boost your portfolio. Continue reading.

StockNews.com

3 Rising Pharma Stocks to Consider Buying Now

The pharmaceutical sector is transforming due to the swift uptake of digital solutions and worldwide spending growth. Hence, fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Astellas Pharma (ALPMY), and Eli Lilly (LLY) might be solid buys now. Read more….

StockNews.com

Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal

Amphastar is IBD Stock Of The Day as the biotech stock revs up marketing of Baqsimi, a drug purchased this year from Eli Lilly.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Are Magnificent Seven Stocks Due For Santa Rally Or Lump Of Coal?

As Magnificent Seven stocks Microsoft, Amazon, Meta and Nvidia pilot IBD Leaderboard, what does Santa and Wall Street have in store?

Investors Business Daily

Pfizer Halts Development Of Twice-Daily Weight-Loss Drug; PFE Stock Slides

Pfizer said Friday it would not advance development of a twice-daily oral weight-loss drug because of its side effects.

Investors Business Daily

Google Leads Five S&P 500 Stocks Near Buy Points

Google leads this watchlist of five S&P 500 stocks near buy points as the market rally has investors seeing green.

Investors Business Daily

This Option Trade On Eli Lilly Stock Could Return 27% By Mid-January

This iron condor trade on Eli Lilly stock has the potential to return 27% if the stock price stays between about 510 and 680.

Investors Business Daily

Top Funds Can't Get Enough Of Amazon — And This Intelligence Play

As a Santa Claus rally begins, the AI boom continues to fuel gains for Palantir and Amazon as top funds place their bets.

Investors Business Daily

Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday

Eli Lilly was an S&P 500 top performer Monday, while energy plays were among the day's biggest winners and losers.

Investors Business Daily

Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review

The major indexes confirmed the new stock market rally, fueled by tumbling Treasury yields. Arista Networks and Palantir were earnings winners.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Rise, Apple Falls On Holiday Outlook; Jobs Report Due

The market roared higher again Thursday, but the jobs report looms large. Apple warned on holiday sales.

Investors Business Daily

Dow Jones Futures Rise: Market Rally Gains Steam On Fed Chief Powell's 'Decay'; Palantir Jumps

Techs led futures higher, with Palantir and Roku among the big earnings winners. Fed chief Jerome Powell signaled no more rate hikes, fueling Wednesday's strong market rally.

StockNews.com

Eli Lilly & Co. (LLY) Earnings Forecast

Drugmaker Eli Lilly and Company (LLY) is scheduled to release its third-quarter results soon. While its revenue is expected to rise sharply over the prior-year quarter, its earnings are expected to decline. So, how should investors position themselves before the results are out? Read on to learn more….

Barchart

Is It Too Late To Buy Eli Lilly Stock?

Eli Lilly stock has crushed the broader markets in the past 10 years. But should you buy LLY at current levels, given its lofty valuation?

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Rise: Market Rally At Key Levels As Inflation Data Looms; Novo Nordisk Soars

The Nasdaq is just above its 50-day line with the CPI inflation report due. Novo Nordisk soared on news that slammed medtech stocks.

Investors Business Daily

Dow Jones Futures Fall, Oil Prices Spike After Hamas Attack

Futures fell and crude oil prices spiked following the Hamas attack on Israel. Nvidia leads 11 stocks flashing buy signals after Friday's bullish upside reversal.

Investors Business Daily

The Point At Which IBD Stock Of The Day Eli Lilly Could Become Actionable Again

Eli Lilly is Friday's IBD Stock Of The Day. After announcing an acquisition, Eli Lilly stock is bounding off its 50-day moving average.

Investors Business Daily

Dow Jones Futures Rise: Jobs Report Due; Tesla Cuts Model 3, Y Prices Again

The jobs report is key for a struggling market rally attempt. Tesla cut Model 3 and Model Y prices again.

StockNews.com

Which Pharma Stock Has More Potential Gains This Month: Pfizer (PFE) or Eli Lilly & Co. (LLY)?

The pharmaceutical industry is poised for sustained long-term growth due to increased investments in drug development and rapid technological advancements. While leading pharma stocks Pfizer (PFE) and Eli Lilly (LLY) stand to benefit, let us analyze which of these giants is poised for more gains this month. Keep reading.

Investors Business Daily

These 5 Stocks Are Setting Up This Buying Opportunity After Strong Runs

After a run, stocks can offer a new buying opportunity with a pullback to the 50-day line. Novo Nordisk and 4 S&P 500 stocks have done that.

Barchart

Here's What $1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth Now

Eli Lilly stock has surged over 1,200% in the last 10 years. Here's why I remain bullish on this blue-chip healthcare stock right now.

1 … 6 7 8 9

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations